Daiwa Securities Group Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$2
-33.3%
900.0%0.00%
Q2 2023$3
-96.9%
90
-97.8%
0.00%
-100.0%
Q1 2023$98
+75.0%
4,109
+23.8%
0.00%
Q4 2022$56
-99.9%
3,320
-31.7%
0.00%
-100.0%
Q3 2022$72,000
-22.6%
4,860
-17.7%
0.00%0.0%
Q2 2022$93,000
-1.1%
5,904
+68.5%
0.00%0.0%
Q1 2022$94,000
+4.4%
3,503
+44.0%
0.00%0.0%
Q4 2021$90,000
-10.9%
2,432
+15.3%
0.00%0.0%
Q3 2021$101,000
+4950.0%
2,110
+4487.0%
0.00%
Q2 2021$2,0000.0%460.0%0.00%
Q1 2021$2,0000.0%460.0%0.00%
Q4 2020$2,000460.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders